Airway diseases
Interstitial lung diseases
Respiratory critical care
Respiratory infections
Oral presentation
New pharmacological strategies in airway diseases
Methods :
Cell and molecular biology, Respiratory intensive care, Surgery, Transplantation, General respiratory patient care, Imaging, Physiology
10:45
Late Breaking Abstract - Aerosolized gold nanoparticles as a vehicle for prolonged donor lung treatment
A. URSO(NEW YORK, United States)
COI
1
11:00
Late Breaking Abstract - CRAC channel inhibition by RP3128 triggers potent anti-inflammatory effects in COPD or asthmatic patient-derived primary cells
S. Viswanadha(La Chaux-de-Fonds, Switzerland)
COI
2
11:15
Late Breaking Abstract - Increased type 2 inflammation in patients with asthma post rhinovirus infection
T. Southworth(Manchester, United Kingdom)
COI
3
11:30
Late Breaking Abstract - Insulin potentiates methacholine and serotonin-induced increases in tracheal smooth muscle intracellular calcium
B. Proskocil(Portland, United States)
COI
4
11:45
Late Breaking Abstract - Development of an ex vivo pediatric preclinical model of bronchopulmonary dysplasia for aerosol regional deposition studies
Y. Montigaud(Saint-Etienne Cedex 2, France)
COI
5
12:00
Late Breaking Abstract - TGF-ß impairs fibroblast ability to support lung organoid formation: pharmacological restoration by GSK-3 inhibition and secreted niche factor supplementation
R. Gosens(Groningen, Netherlands)
COI
6
12:15
Late Breaking Abstract - Daily physical activity in patients with severe eosinophilic asthma and the effect of anti-IL5 therapy.
M. PANAGIOTOU(Athens, Greece)
COI
7
12:30
Late Breaking Abstract - Explore the effective dose of bronchodilator nebulization via high flow nasal cannula in adult COPD and asthma patients
J. Li(Chicago, United States)
COI
8
. . .
